Genmab, DK0010272202

Genmab stock at DKK 2,277 on September 25, 2026, up 0.40 percent

Published on 09/26/2026 at 18:03 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Genmab shares last traded at DKK 2,277 on Nasdaq Copenhagen on September 25, 2026, up 0.40 percent. The company also announced employee share awards and warrants.

Fotorealistisches Biotech-Labor mit Forschern in weißen Kitteln bei Antikörperforschung
Genmab A/S entwickelt Antikörpertherapien in modernen Biotech-Laboren mit Forschern und Präzisionsgeräten, Aktie DK0010272202, Illustration mit AI erstellt.

Trading session

Genmab A/S shares on Nasdaq Copenhagen last traded at DKK 2,277 at 2:59:52 PM UTC on September 25, 2026. The stock was up DKK 9, or 0.40 percent, from the previous close of DKK 2,268.

Employee share awards announced

In a company announcement dated September 24, 2026, Genmab A/S said its board had approved grants of 13,794 restricted stock units and 13,331 warrants to employees of Genmab and its subsidiaries.

The restricted stock units were awarded at no cost and provide a conditional right to receive one Genmab A/S share. The units vest on the first banking day of the month following three years from the grant date, subject to the program’s conditions. The warrants also were awarded at no cost, carry an exercise price of DKK 2,268 and vest after three years. They expire on the seventh anniversary of the grant date, while their Black-Scholes fair value was DKK 781.96, according to the announcement.

Disclaimer...

en | DK0010272202 | GENMAB | boerse | 70186867 | bgmi